Comparing two ways to wean preterm babies from high-frequency oscillatory ventilation
Official title: Randomized Controlled Trial of Two Protocols for Weaning From High Frequency Oscillatory Ventilation in Preterm Neonates With Respiratory Distress Syndrome
Run by Mansoura University Children Hospital · NCT07202299 · Data updated 2026-11-12
This trial tests two different methods to stop high-frequency oscillatory ventilation in preterm infants with respiratory distress syndrome to see which leads to fewer complications.
Quick facts
| Study type | Interventional |
|---|---|
| Sex | All |
| Enrollment | 110 (estimated) |
| Sponsor | Mansoura University Children Hospital Academic / other |
| Locations | 1 site (Al Mansurah) |
| Status | Recruiting |
| Started | September 22, 2025 |
| Main results expected | March 2027 |
| Study ends | September 2027 |
| Registry record updated | October 1, 2025 |
| Trial ID | NCT07202299 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Preterm infants (gestational age ≤34 weeks) with respiratory distress syndrome who required HFOV for more than 24 hours after failing noninvasive respiratory support are eligible.
✕Probably not a fit
Infants with major congenital malformations, chromosomal abnormalities, inborn errors of metabolism, or severe intraventricular hemorrhage (grade III/IV) are excluded and would not be expected to benefit from the trial protocol results.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an open-label randomized trial enrolling preterm infants (≤34 weeks gestation) with respiratory distress syndrome who have been on high-frequency oscillatory ventilation (HFOV) for more than 24 hours after failure of noninvasive support. Enrolled infants are randomly assigned to one of two predefined HFOV weaning protocols and managed in the NICU at Mansoura University Children Hospital. Outcomes will include measures of successful weaning, duration of mechanical support, and frequency of complications such as apnea, hypoxemia, or need to return to HFOV. The trial aims to identify a practical weaning approach that minimizes ventilation time and adverse events in this population.
Why it matters
Potential benefit: If successful, the preferred protocol could shorten time on HFOV and reduce complications for preterm infants with respiratory distress syndrome.
How similar studies have gone: There are limited randomized trials comparing HFOV weaning protocols and some observational reports support protocolized weaning, but high-quality evidence is still sparse.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Preterm infants with RDS whose gestational age is 34 weeks or less who required HFOV for more than 24 hours duration due to failure of non- invasive respiratory support due to any of the following: 1. Severe hypercapnea PaCO2 \> 60 mmHg associated with pH \< 7.25. 2. Hypoxemia PaO2 \< 50 mmHg, with FiO2 \> 40%. 3. Frequent apneas: 6 or more episodes of apnea requiring mild or moderate stimulation within 6-hour period or one apneic episode requiring bag and mask positive pressure ventilation. Exclusion Criteria: Preterm infants with any of the following : 1. Major congenital malformations or chromosomal aberrations. 2. Inborn errors of metabolism. 3. Severe intraventricular hemorrhage (IVH) grade III or IV
Where it's running
-
Mansoura University Children Hospital
Al Mansurah, Egypt Recruiting
Study contacts
- Study coordinator: Yasmina E Keshta
- Email: yasminakeshta@mans.edu.eg
- Phone: +201010166023
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
How Different Levels of CPAP Deliver Oxygen to Preterm Babies
This study tests how much oxygen actually reaches preterm infants when they receive nasal CPAP at different air pressures.
-
Surfactant delivery methods in preterm infants with RDS in Sweden
This study tests different ways of giving surfactant to preterm babies with respiratory distress to see which method works best when care is routine.
-
Video-guided vs direct laryngoscopy for less invasive surfactant delivery in extremely preterm infants
This trial tests whether using video laryngoscopy helps give surfactant on the first try more often than direct laryngoscopy in extremely preterm babies needing surfactant.
-
Lung volume changes with synchronized noninvasive ventilator support in preterm infants
This study will use a noninvasive imaging belt to see if synchronized ventilator inflations produce larger lung volumes than unsynchronized or backup inflations in very preterm infants on sNIPPV.
-
SalSA vs LISA: Surfactant Delivery in Preterm Infants
This study tests whether giving surfactant through SALSA (a supraglottic airway) is safer and more effective than the LISA thin-catheter method in babies born at 29-36 weeks who need help breathing.
-
Comparing video laryngoscopy and direct laryngoscopy for surfactant administration in newborns
This study is testing whether using video laryngoscopy makes it easier to insert a breathing tube for surfactant treatment in newborns with breathing problems compared to the standard method.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.